Varied Lidocaine Injection Methods for Pain Management
Trial Summary
What is the purpose of this trial?
This study will collect data from multiple academic institutions. The primary objective for part A of this study is to determine the impact of anesthetic injection rate and temperature on pain perception during dermatologic procedures, and the objective for the part B of this study is to determine if buffering of the anesthetic solution alters pain perception.This study is a pilot study designed to determine feasibility of these procedures.
Research Team
Murad Alam, MD
Principal Investigator
Northwestern University
Eligibility Criteria
This trial is for individuals aged 18-89 who are about to undergo dermatologic procedures and can understand and agree to the study's terms. It's not suitable for those who don't meet these age requirements or cannot give informed consent.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment Part A
Participants receive injections of lidocaine at varying rates and temperatures to assess pain perception
Treatment Part B
Participants receive injections of buffered or non-buffered lidocaine to assess pain perception
Follow-up
Participants are monitored for any immediate adverse effects post-injection
Treatment Details
Interventions
- Buffer
- Lidocaine
Lidocaine is already approved in United States, European Union, Canada for the following indications:
- Local anesthesia for minor surgical procedures
- Surface anesthesia for minor procedures
- Spinal anesthesia
- Epidural anesthesia
- Local anesthesia
- Regional anesthesia
- Surface anesthesia
- Local anesthesia
- Regional anesthesia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor